245 related articles for article (PubMed ID: 15122208)
1. Molecules and mechanisms of the graft-versus-leukaemia effect.
Bleakley M; Riddell SR
Nat Rev Cancer; 2004 May; 4(5):371-80. PubMed ID: 15122208
[No Abstract] [Full Text] [Related]
2. [Role of minor histocompatibility antigens in hematopoietic cell transplantation].
Akatsuka Y
Rinsho Ketsueki; 2006 Oct; 47(10):1353-63. PubMed ID: 17094574
[No Abstract] [Full Text] [Related]
3. Adoptive transfer of allogeneic antigen-specific T cells.
Riddell SR; Bleakley M; Nishida T; Berger C; Warren EH
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):9-12. PubMed ID: 16399578
[TBL] [Abstract][Full Text] [Related]
4. [Polymorphic adhesion molecules mediating the graft-versus-leukemia effect].
Takami A; Nakao S
Rinsho Ketsueki; 2004 Mar; 45(3):183-8. PubMed ID: 15103930
[No Abstract] [Full Text] [Related]
5. Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice.
Hambach L; Nijmeijer BA; Aghai Z; Schie ML; Wauben MH; Falkenburg JH; Goulmy E
Leukemia; 2006 Feb; 20(2):371-4. PubMed ID: 16357839
[No Abstract] [Full Text] [Related]
6. Minor histocompatibility antigens as targets of cellular immunotherapy in leukaemia.
Falkenburg JH; Willemze R
Best Pract Res Clin Haematol; 2004 Sep; 17(3):415-25. PubMed ID: 15498713
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of cancer through targeting of minor histocompatibility antigens.
Hambach L; Goulmy E
Curr Opin Immunol; 2005 Apr; 17(2):202-10. PubMed ID: 15766682
[TBL] [Abstract][Full Text] [Related]
8. [Possibility of selective induction of a GVL effect without increasing GVHD].
Akatsuka Y
Rinsho Ketsueki; 2008 Aug; 49(8):607-15. PubMed ID: 18800609
[No Abstract] [Full Text] [Related]
9. [Minor antigens - major impact. The role of minor histocompatibility antigens in allogeneic hematopoietic stem cell transplantation].
Hudecek M; Bartsch K; Tschiedel S; Niederwieser D
Dtsch Med Wochenschr; 2008 Jul; 133(28-29):1511-6. PubMed ID: 18597211
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of minor histocompatibility antigen immunogenicity: the role of infinitesimal versus structurally profound polymorphisms.
Brickner AG
Immunol Res; 2006; 36(1-3):33-41. PubMed ID: 17337764
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic strategies in acute lymphoblastic leukaemia relapsing after stem cell transplantation.
Blair A; Goulden NJ; Libri NA; Oakhill A; Pamphilon DH
Blood Rev; 2005 Nov; 19(6):289-300. PubMed ID: 16275419
[TBL] [Abstract][Full Text] [Related]
12. [To strengthen study on graft versus leukemia].
Ye G
Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):397-8. PubMed ID: 11718087
[No Abstract] [Full Text] [Related]
13. Targeting alloreactive T cells to hematopoietic system specific minor histocompatibility antigens for cellular immunotherapy of hematological malignancies after stem cell transplantation.
Mutis T; Goulmy E
Ann Hematol; 2002; 81 Suppl 2():S38-9. PubMed ID: 12611070
[No Abstract] [Full Text] [Related]
14. Mismatch of minor histocompatibility antigen contributes to a graft-versus-leukemia effect rather than to acute GVHD, resulting in long-term survival after HLA-identical stem cell transplantation in Japan.
Katagiri T; Shiobara S; Nakao S; Wakano M; Muranaka E; Kuba N; Furukawa T; Tsukada J; Takeda H; Aizawa Y; Harada M
Bone Marrow Transplant; 2006 Nov; 38(10):681-6. PubMed ID: 16980988
[TBL] [Abstract][Full Text] [Related]
15. Targeting haematopoietic-specific minor histocompatibility antigens to distinguish graft-versus-tumour effects from graft-versus-host disease.
Spaapen R; Mutis T
Best Pract Res Clin Haematol; 2008 Sep; 21(3):543-57. PubMed ID: 18790454
[TBL] [Abstract][Full Text] [Related]
16. Expansion and activation of minor histocompatibility antigen HY-specific T cells associated with graft-versus-leukemia response.
Takami A; Sugimori C; Feng X; Yachie A; Kondo Y; Nishimura R; Kuzushima K; Kotani T; Asakura H; Shiobara S; Nakao S
Bone Marrow Transplant; 2004 Oct; 34(8):703-9. PubMed ID: 15322566
[TBL] [Abstract][Full Text] [Related]
17. [Antigen-specific allogeneic immunotherapy--selective augmentation of GVL effects].
Akatsuka Y
Gan To Kagaku Ryoho; 2008 May; 35(5):713-9. PubMed ID: 18487905
[TBL] [Abstract][Full Text] [Related]
18. Kappa immunoglobulin light chain polymorphisms and survival after allogeneic transplantation for B-cell malignancies: a potential graft-vs-leukaemia target.
Etto TL; Stewart LA; Muirhead J; Bailey M; Schwarer AP
Tissue Antigens; 2007 Jan; 69(1):56-61. PubMed ID: 17212708
[TBL] [Abstract][Full Text] [Related]
19. Minor histocompatibility antigens: targets for tumour therapy and transplant tolerance.
Spierings E
Int J Immunogenet; 2008 Aug; 35(4-5):363-6. PubMed ID: 18976439
[TBL] [Abstract][Full Text] [Related]
20. T-cell therapy after hematopoietic stem cell transplantation.
Kennedy-Nasser AA; Brenner MK
Curr Opin Hematol; 2007 Nov; 14(6):616-24. PubMed ID: 17898565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
